世界の糖尿病性足潰瘍治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetic Foot Ulcer Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4122 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、糖尿病性足潰瘍治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置）、用途別市場規模（病院、専門クリニック、介護センター、外来外科センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・糖尿病性足潰瘍治療薬の市場動向 ・企業の競争状況、市場シェア ・糖尿病性足潰瘍治療薬の種類別市場規模と予測2016-2027（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置） ・糖尿病性足潰瘍治療薬の用途別市場規模と予測2016-2027（病院、専門クリニック、介護センター、外来外科センター） ・糖尿病性足潰瘍治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病性足潰瘍治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病性足潰瘍治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病性足潰瘍治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病性足潰瘍治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（B. Braun Melsungen AG、Smith & Nephew, Inc.、Organogenesis, Inc.、Derma Sciences Inc.、Sigvaris Inc.、3M、Acelity L.P. Inc.、Innocoll Holdings plc.、SIGVARIS, Inc.） ・結論

Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutic Market
The global Diabetic Foot Ulcer Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Foot Ulcer Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Foot Ulcer Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Foot Ulcer Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Foot Ulcer Therapeutic market.

Global Diabetic Foot Ulcer Therapeutic Scope and Market Size
Diabetic Foot Ulcer Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Foot Ulcer Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices

Segment by Application
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
B. Braun Melsungen AG
Smith & Nephew, Inc.
Organogenesis, Inc.
Derma Sciences Inc.
Sigvaris Inc.
3M
Acelity L.P. Inc.
Innocoll Holdings plc.
SIGVARIS, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Advance Wound Dressings
1.2.3 Skin Substitutes
1.2.4 Negative Pressure Wound Therapy Devices
1.3 Market by Application
1.3.1 Global Diabetic Foot Ulcer Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Long-Term Care Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Foot Ulcer Therapeutic Market Perspective (2016-2027)
2.2 Diabetic Foot Ulcer Therapeutic Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Foot Ulcer Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Foot Ulcer Therapeutic Industry Dynamic
2.3.1 Diabetic Foot Ulcer Therapeutic Market Trends
2.3.2 Diabetic Foot Ulcer Therapeutic Market Drivers
2.3.3 Diabetic Foot Ulcer Therapeutic Market Challenges
2.3.4 Diabetic Foot Ulcer Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Foot Ulcer Therapeutic Players by Revenue
3.1.1 Global Top Diabetic Foot Ulcer Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Foot Ulcer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Foot Ulcer Therapeutic Revenue
3.4 Global Diabetic Foot Ulcer Therapeutic Market Concentration Ratio
3.4.1 Global Diabetic Foot Ulcer Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Foot Ulcer Therapeutic Revenue in 2020
3.5 Diabetic Foot Ulcer Therapeutic Key Players Head office and Area Served
3.6 Key Players Diabetic Foot Ulcer Therapeutic Product Solution and Service
3.7 Date of Enter into Diabetic Foot Ulcer Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Foot Ulcer Therapeutic Breakdown Data by Type
4.1 Global Diabetic Foot Ulcer Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Type (2022-2027)

5 Diabetic Foot Ulcer Therapeutic Breakdown Data by Application
5.1 Global Diabetic Foot Ulcer Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Foot Ulcer Therapeutic Market Size (2016-2027)
6.2 North America Diabetic Foot Ulcer Therapeutic Market Size by Type
6.2.1 North America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2027)
6.3 North America Diabetic Foot Ulcer Therapeutic Market Size by Application
6.3.1 North America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2027)
6.4 North America Diabetic Foot Ulcer Therapeutic Market Size by Country
6.4.1 North America Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diabetic Foot Ulcer Therapeutic Market Size (2016-2027)
7.2 Europe Diabetic Foot Ulcer Therapeutic Market Size by Type
7.2.1 Europe Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2027)
7.3 Europe Diabetic Foot Ulcer Therapeutic Market Size by Application
7.3.1 Europe Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2027)
7.4 Europe Diabetic Foot Ulcer Therapeutic Market Size by Country
7.4.1 Europe Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type
8.2.1 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application
8.3.1 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Region
8.4.1 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Foot Ulcer Therapeutic Market Size (2016-2027)
9.2 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type
9.2.1 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application
9.3.1 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Country
9.4.1 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type
10.2.1 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application
10.3.1 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Country
10.4.1 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Details
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Introduction
11.1.4 B. Braun Melsungen AG Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Smith & Nephew, Inc.
11.2.1 Smith & Nephew, Inc. Company Details
11.2.2 Smith & Nephew, Inc. Business Overview
11.2.3 Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.2.4 Smith & Nephew, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.2.5 Smith & Nephew, Inc. Recent Development
11.3 Organogenesis, Inc.
11.3.1 Organogenesis, Inc. Company Details
11.3.2 Organogenesis, Inc. Business Overview
11.3.3 Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.3.4 Organogenesis, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.3.5 Organogenesis, Inc. Recent Development
11.4 Derma Sciences Inc.
11.4.1 Derma Sciences Inc. Company Details
11.4.2 Derma Sciences Inc. Business Overview
11.4.3 Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.4.4 Derma Sciences Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.4.5 Derma Sciences Inc. Recent Development
11.5 Sigvaris Inc.
11.5.1 Sigvaris Inc. Company Details
11.5.2 Sigvaris Inc. Business Overview
11.5.3 Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.5.4 Sigvaris Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.5.5 Sigvaris Inc. Recent Development
11.6 3M
11.6.1 3M Company Details
11.6.2 3M Business Overview
11.6.3 3M Diabetic Foot Ulcer Therapeutic Introduction
11.6.4 3M Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.6.5 3M Recent Development
11.7 Acelity L.P. Inc.
11.7.1 Acelity L.P. Inc. Company Details
11.7.2 Acelity L.P. Inc. Business Overview
11.7.3 Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.7.4 Acelity L.P. Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.7.5 Acelity L.P. Inc. Recent Development
11.8 Innocoll Holdings plc.
11.8.1 Innocoll Holdings plc. Company Details
11.8.2 Innocoll Holdings plc. Business Overview
11.8.3 Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Introduction
11.8.4 Innocoll Holdings plc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.8.5 Innocoll Holdings plc. Recent Development
11.9 SIGVARIS, Inc.
11.9.1 SIGVARIS, Inc. Company Details
11.9.2 SIGVARIS, Inc. Business Overview
11.9.3 SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Introduction
11.9.4 SIGVARIS, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
11.9.5 SIGVARIS, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Advance Wound Dressings
Table 3. Key Players of Skin Substitutes
Table 4. Key Players of Negative Pressure Wound Therapy Devices
Table 5. Global Diabetic Foot Ulcer Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Foot Ulcer Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Foot Ulcer Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diabetic Foot Ulcer Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diabetic Foot Ulcer Therapeutic Market Share by Regions (2022-2027)
Table 11. Diabetic Foot Ulcer Therapeutic Market Trends
Table 12. Diabetic Foot Ulcer Therapeutic Market Drivers
Table 13. Diabetic Foot Ulcer Therapeutic Market Challenges
Table 14. Diabetic Foot Ulcer Therapeutic Market Restraints
Table 15. Global Diabetic Foot Ulcer Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diabetic Foot Ulcer Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Diabetic Foot Ulcer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutic as of 2020)
Table 18. Ranking of Global Top Diabetic Foot Ulcer Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diabetic Foot Ulcer Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Foot Ulcer Therapeutic Product Solution and Service
Table 22. Date of Enter into Diabetic Foot Ulcer Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diabetic Foot Ulcer Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Diabetic Foot Ulcer Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. B. Braun Melsungen AG Company Details
Table 63. B. Braun Melsungen AG Business Overview
Table 64. B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Product
Table 65. B. Braun Melsungen AG Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 66. B. Braun Melsungen AG Recent Development
Table 67. Smith & Nephew, Inc. Company Details
Table 68. Smith & Nephew, Inc. Business Overview
Table 69. Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Product
Table 70. Smith & Nephew, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Smith & Nephew, Inc. Recent Development
Table 72. Organogenesis, Inc. Company Details
Table 73. Organogenesis, Inc. Business Overview
Table 74. Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Product
Table 75. Organogenesis, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Organogenesis, Inc. Recent Development
Table 77. Derma Sciences Inc. Company Details
Table 78. Derma Sciences Inc. Business Overview
Table 79. Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Product
Table 80. Derma Sciences Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Derma Sciences Inc. Recent Development
Table 82. Sigvaris Inc. Company Details
Table 83. Sigvaris Inc. Business Overview
Table 84. Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Product
Table 85. Sigvaris Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Sigvaris Inc. Recent Development
Table 87. 3M Company Details
Table 88. 3M Business Overview
Table 89. 3M Diabetic Foot Ulcer Therapeutic Product
Table 90. 3M Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 91. 3M Recent Development
Table 92. Acelity L.P. Inc. Company Details
Table 93. Acelity L.P. Inc. Business Overview
Table 94. Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Product
Table 95. Acelity L.P. Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Acelity L.P. Inc. Recent Development
Table 97. Innocoll Holdings plc. Company Details
Table 98. Innocoll Holdings plc. Business Overview
Table 99. Innocoll Holdings plc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Innocoll Holdings plc. Recent Development
Table 101. SIGVARIS, Inc. Company Details
Table 102. SIGVARIS, Inc. Business Overview
Table 103. SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Product
Table 104. SIGVARIS, Inc. Revenue in Diabetic Foot Ulcer Therapeutic Business (2016-2021) & (US$ Million)
Table 105. SIGVARIS, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Foot Ulcer Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Advance Wound Dressings Features
Figure 3. Skin Substitutes Features
Figure 4. Negative Pressure Wound Therapy Devices Features
Figure 5. Global Diabetic Foot Ulcer Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Long-Term Care Centers Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diabetic Foot Ulcer Therapeutic Report Years Considered
Figure 11. Global Diabetic Foot Ulcer Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diabetic Foot Ulcer Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diabetic Foot Ulcer Therapeutic Market Share by Regions: 2020 VS 2027
Figure 14. Global Diabetic Foot Ulcer Therapeutic Market Share by Regions (2022-2027)
Figure 15. Global Diabetic Foot Ulcer Therapeutic Market Share by Players in 2020
Figure 16. Global Top Diabetic Foot Ulcer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutic Revenue in 2020
Figure 18. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type (2016-2021)
Figure 19. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type (2022-2027)
Figure 20. North America Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diabetic Foot Ulcer Therapeutic Market Share by Type (2016-2027)
Figure 22. North America Diabetic Foot Ulcer Therapeutic Market Share by Application (2016-2027)
Figure 23. North America Diabetic Foot Ulcer Therapeutic Market Share by Country (2016-2027)
Figure 24. United States Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetic Foot Ulcer Therapeutic Market Share by Type (2016-2027)
Figure 28. Europe Diabetic Foot Ulcer Therapeutic Market Share by Application (2016-2027)
Figure 29. Europe Diabetic Foot Ulcer Therapeutic Market Share by Country (2016-2027)
Figure 30. Germany Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diabetic Foot Ulcer Therapeutic Market Share by Region (2016-2027)
Figure 40. China Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetic Foot Ulcer Therapeutic Market Share by Type (2016-2027)
Figure 48. Latin America Diabetic Foot Ulcer Therapeutic Market Share by Application (2016-2027)
Figure 49. Latin America Diabetic Foot Ulcer Therapeutic Market Share by Country (2016-2027)
Figure 50. Mexico Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diabetic Foot Ulcer Therapeutic Market Share by Country (2016-2027)
Figure 56. Turkey Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diabetic Foot Ulcer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. B. Braun Melsungen AG Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 60. Smith & Nephew, Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 61. Organogenesis, Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 62. Derma Sciences Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 63. Sigvaris Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 64. 3M Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 65. Acelity L.P. Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 66. Innocoll Holdings plc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 67. SIGVARIS, Inc. Revenue Growth Rate in Diabetic Foot Ulcer Therapeutic Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---